Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

LABNOVATION TECHNOLOGIES

Labnovation Technologies, Inc. develops, manufactures and markets various clinical laboratory instruments and diagnos... read more Featured Products: More products

Download Mobile App





BioGiox and Labnovation Showcase Molecular Diagnostics and HbA1c Testing at MEDICA 2026

By LabMedica International staff writers
Posted on 16 Nov 2026

BioGiox and Labnovation showcase a range of diagnostic technologies at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. More...

The companies highlight solutions for high-performance liquid chromatography (HPLC), thalassemia screening, molecular diagnostics, and point-of-care testing (POCT), alongside new immunoassays for Alzheimer's disease-related biomarkers.

Among the featured technologies are HPLC-based testing solutions for glycated hemoglobin (HbA1c) measurement and thalassemia screening. Labnovation's portfolio includes the LD-560 and LD-600 fully automated HbA1c analyzers, which use HPLC technology to quantify glycated hemoglobin. The systems offer testing speeds of approximately 90 and 65 seconds per sample, respectively, with automated sample loading capabilities.

The LD-560 and LD-600 also support hemoglobin variant analysis, including the detection of HbS, HbC, HbD, and HbE. Their testing capabilities extend to the measurement of HbA2 and HbF, which are relevant to thalassemia screening and the evaluation of hemoglobin disorders. These functions enable laboratories to perform diabetes monitoring and hemoglobin analysis using a single instrument platform.

For decentralized testing, the companies highlight point-of-care HbA1c and molecular diagnostic solutions. Labnovation's LD-100 HbA1c analyzer uses the boronate affinity method to measure glycated hemoglobin in whole blood or fingertip blood samples. The compact instrument delivers results in under three minutes and is designed for use in clinical laboratories, hospitals, and outpatient settings.

The molecular diagnostics portfolio includes automated technologies for nucleic acid extraction and PCR preparation. BioGiox's BG-Star-96 workstation integrates sample processing, nucleic acid extraction, and PCR reaction preparation into a single automated workflow. The system completes extraction and PCR preparation in approximately 40 minutes and supports simultaneous preparation of six different PCR assays.

The company also offers rapid molecular testing platforms, including the Flix disc CH-0104 fully automated nucleic acid analyzer. The cartridge-based system integrates nucleic acid extraction and amplification, supporting detection of up to 16 targets in approximately 30–45 minutes. Its enclosed design and modular configuration, expandable to eight modules, are intended to support decentralized infectious disease testing.

Another highlight is BioGiox's new portfolio of immunoassays targeting biomarkers associated with Alzheimer's disease and neurodegeneration. The assays include phosphorylated tau 217 (p-Tau217), phosphorylated tau 181 (p-Tau181), neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), and amyloid-beta 1-40 and 1-42. These blood-based biomarkers are being investigated for their role in disease assessment and monitoring.

The Alzheimer's-related assays are designed for automated chemiluminescence immunoassay platforms, supporting laboratory analysis of multiple biomarkers involved in amyloid pathology, tau pathology, and neurodegeneration. According to BioGiox, its testing platform can deliver initial results in approximately 20 minutes, with throughput of up to 200 tests per hour, depending on the assay and instrument configuration.

BioGiox and Labnovation exhibit at Booth E43 in Hall 1, where visitors can explore their diagnostic technologies and discuss potential collaborations. Their participation highlights applications ranging from routine diabetes monitoring and molecular infectious disease testing to emerging blood-based biomarker assays for neurodegenerative diseases.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: iStock

AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health

Advances in molecular diagnostics are creating new opportunities to improve the detection of sexually transmitted infections, identify antibiotic resistance, and assess cancer recurrence risk in women.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.